Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caspian Biotech is an active Iranian biotechnology company established in 2015. It supplies laboratory and industrial bioreactors and related equipment for the production of recombinant drugs—including vaccines, biosimilars, monoclonal antibodies (mAbs), plasma-derived therapies, enzymes, and probiotics. The company also offers services in technology transfer for injectable drugs and laboratory products. With about 30 employees across five departments—engineering/technical support, sales/marketing, biotech/technology transfer, injectable & chemical drugs division, commercial/logistics—it operates both domestically in Iran and internationally with branches in UAE, Turkey, and USA[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caspian.